These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 19586676)
21. Impact of Il28b-related single nucleotide polymorphisms on liver transient elastography in chronic hepatitis C infection. Ydreborg M; Westin J; Rembeck K; Lindh M; Norrgren H; Holmberg A; Wejstål R; Norkrans G; Cardell K; Weiland O; Lagging M PLoS One; 2013; 8(11):e80172. PubMed ID: 24244641 [TBL] [Abstract][Full Text] [Related]
22. A Toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infection. Schott E; Witt H; Neumann K; Taube S; Oh DY; Schreier E; Vierich S; Puhl G; Bergk A; Halangk J; Weich V; Wiedenmann B; Berg T J Hepatol; 2007 Aug; 47(2):203-11. PubMed ID: 17512627 [TBL] [Abstract][Full Text] [Related]
23. Rapidity of fibrosis progression in liver transplant recipients with recurrent hepatitis C is influenced by toll-like receptor 3 polymorphism. Citores MJ; Pérez-Pulgar S; Duca A; Crespo G; de la Fuente S; Vilches C; Navasa M; Cuervas-Mons V Clin Transplant; 2016 Jul; 30(7):810-8. PubMed ID: 27101936 [TBL] [Abstract][Full Text] [Related]
24. Fine mapping analysis of HLA-DP/DQ gene clusters on chromosome 6 reveals multiple susceptibility loci for HBV infection. Tao J; Su K; Yu C; Liu X; Wu W; Xu W; Jiang B; Luo R; Yao J; Zhou J; Zhan Y; Ye C; Yuan W; Jiang X; Cui W; Li MD; Li L Amino Acids; 2015 Dec; 47(12):2623-34. PubMed ID: 26197724 [TBL] [Abstract][Full Text] [Related]
25. Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma. Lange CM; Bibert S; Dufour JF; Cellerai C; Cerny A; Heim MH; Kaiser L; Malinverni R; Müllhaupt B; Negro F; Semela D; Moradpour D; Kutalik Z; Bochud PY; J Hepatol; 2013 Sep; 59(3):504-9. PubMed ID: 23665287 [TBL] [Abstract][Full Text] [Related]
31. PNPLA3 rs738409 Polymorphism Associated with Hepatic Steatosis and Advanced Fibrosis in Patients with Chronic Hepatitis C Virus: A Meta-Analysis. Fan JH; Xiang MQ; Li QL; Shi HT; Guo JJ Gut Liver; 2016 May; 10(3):456-63. PubMed ID: 26419236 [TBL] [Abstract][Full Text] [Related]
32. Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C. Trépo E; Pradat P; Potthoff A; Momozawa Y; Quertinmont E; Gustot T; Lemmers A; Berthillon P; Amininejad L; Chevallier M; Schlué J; Kreipe H; Devière J; Manns M; Trépo C; Sninsky J; Wedemeyer H; Franchimont D; Moreno C Hepatology; 2011 Jul; 54(1):60-9. PubMed ID: 21488075 [TBL] [Abstract][Full Text] [Related]
33. Hepatic TLR4, MBL and CRP gene expression levels are associated with chronic hepatitis C. de Souza Pires-Neto O; da Silva Graça Amoras E; Queiroz MAF; Demachki S; da Silva Conde SR; Ishak R; Cayres-Vallinoto IMV; Vallinoto ACR Infect Genet Evol; 2020 Jun; 80():104200. PubMed ID: 31962161 [TBL] [Abstract][Full Text] [Related]
34. Impact of common risk factors of fibrosis progression in chronic hepatitis C. Rüeger S; Bochud PY; Dufour JF; Müllhaupt B; Semela D; Heim MH; Moradpour D; Cerny A; Malinverni R; Booth DR; Suppiah V; George J; Argiro L; Halfon P; Bourlière M; Talal AH; Jacobson IM; Patin E; Nalpas B; Poynard T; Pol S; Abel L; Kutalik Z; Negro F Gut; 2015 Oct; 64(10):1605-15. PubMed ID: 25214320 [TBL] [Abstract][Full Text] [Related]
35. Role of CYP2D6 polymorphism in predicting liver fibrosis progression rate in Caucasian patients with chronic hepatitis C. Fishman S; Lurie Y; Peretz H; Morad T; Grynberg E; Blendis LM; Leshno M; Brazowski E; Rosner G; Halpern Z; Oren R Liver Int; 2006 Apr; 26(3):279-84. PubMed ID: 16584388 [TBL] [Abstract][Full Text] [Related]
36. The CXCL1 rs4074 A allele is associated with enhanced CXCL1 responses to TLR2 ligands and predisposes to cirrhosis in HCV genotype 1-infected Caucasian patients. Nischalke HD; Berger C; Luda C; Müller T; Berg T; Coenen M; Krämer B; Körner C; Trebicka J; Grünhage F; Lammert F; Nattermann J; Sauerbruch T; Spengler U J Hepatol; 2012 Apr; 56(4):758-64. PubMed ID: 22173151 [TBL] [Abstract][Full Text] [Related]
37. IL17A gene polymorphisms: relationship to predisposition for chronic viral hepatitis and progression to liver cirrhosis in kazakh population. Massabayeva MR; Aukenov NE; Mussazhanova ZB; Saenko VA; Rogounovitch TI; Shaimardanov NK; Kurmanova BR; Barkibaeva NR; Rakhypbekov TK Vopr Virusol; 2016; 61(5):212-9. PubMed ID: 29323853 [TBL] [Abstract][Full Text] [Related]
38. Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infection. Huang CF; Dai CY; Yeh ML; Huang CI; Tai CM; Hsieh MH; Liang PC; Lin YH; Hsieh MY; Yang HL; Huang JF; Lin ZY; Chen SC; Yu ML; Chuang WL J Hepatol; 2015 Mar; 62(3):512-8. PubMed ID: 25457210 [TBL] [Abstract][Full Text] [Related]
39. Role of genetic polymorphisms in the progression of liver fibrosis in chronic hepatitis C virus infection. Papatheodoridis GV; Paraskevis D Liver Int; 2008 Jul; 28(6):764-6. PubMed ID: 18647140 [No Abstract] [Full Text] [Related]
40. Pleiotropy and allelic heterogeneity in the TOMM40-APOE genomic region related to clinical and metabolic features of hepatitis C infection. Chiba-Falek O; Linnertz C; Guyton J; Gardner SD; Roses AD; McCarthy JJ; Patel K Hum Genet; 2012 Dec; 131(12):1911-20. PubMed ID: 22898894 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]